Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how the FDA has cleared eight more SPMS patients for treatment with foralumab nasal spray, under a special access program.

He also reads “Crossing the Lemtrada Finish Line”, a column by Ed Tobias.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/